
About Averco Global Private Limited
Data last updated:
Averco Global Private Limited is a private limited company based in Noida, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 08 July 2022.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U33119UP2022PTC167319. Its GSTIN is 09AAXCA3085B1ZG (Uttar Pradesh).
The company has an authorised share capital of ₹65 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Raman Deep Kaur and Neeraj Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mahila Udyami Park, Noida, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.12 Cr. For the same year it recorded a net profit of ₹1.37 Lakh (net margin 1.2%) and EBITDA of ₹2.14 Lakh (EBITDA margin 1.9%).
As per MCA filings, the company has open charges of ₹2 Cr on record.
Averco Global Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0056548). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website avercoglobal.com.
Company details
Recognitions & Rankings of Averco Global
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-50-0056548
Contact details
Averco Global Private Limited's registered office is in Noida, Uttar Pradesh. Its website is avercoglobal.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressIndustrial Plot No – 20 Floor No – 1 2 And Terrace Block – Mahila Udyami Park – II, Sector – Ecotech – III, Noida, Uttar Pradesh, India – 201306
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Averco Global Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Averco Global Private Limited
FY 2025 filings availableAverco Global Private Limited reported revenue of ₹1.12 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.14 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.37 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.9% | ||
| Net Profit Margin | 1.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Averco Global Private Limited, buy the company report.
Board of directors and KMP of Averco Global Private Limited
Averco Global Private Limited currently reports 3 directors and 1 key managerial person. 1 former director has served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raman Deep Kaur Also directs: Plutark Meditech Private Limited, Amexa Tech Services Private Limited, Sripharma Lifesciences Private Limited and 2 more | Director | 10 Jun 2024 | 2 Years 4 Months | Current |
| Neeraj Gupta | Director | 07 Apr 2025 | 1 Years 6 Months | Current |
| Sri Kant Singh Also directs: Plutark Meditech Private Limited, Medieval Medical India Private Limited, Amexa Tech Services Private Limited and 2 more | Ceo | 21 Apr 2025 | 1 Years 6 Months | Current |
| Ravi Kant Singh Also directs: Amexa Tech Services Private Limited, Sripharma Lifesciences Private Limited, Ryansh Food and Beverages Private Limited and 1 more | Director | 10 Jun 2024 | 2 Years 4 Months | Current |
Peer comparison
Averco Global Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Medical Consumables), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medizysis India Private Limited | ₹1.17 Cr (FY 2024) | 16.0% | Hasanpur, Delhi, India | |||
| Think Big Systems Private Limited | ₹1.13 Cr (FY 2025) | -6.0% | Delhi, India | |||
| Averco Global Private Limitedthis company | ₹1.12 Cr (FY 2025) | ₹1.37 Lakh | 1.2% | Noida, Uttar Pradesh, India | ||
| Celery Pharma Private Limited | ₹1.09 Cr (FY 2024) | 3.0% | New Delhi, Delhi, India |
To see the full peer comparison of Averco Global Private Limited, buy the company report.
Auditor
Averco Global Private Limited is audited by SINGH & NAGAYACH for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SINGH & NAGAYACH | FY 2023 | 014131C |
Shareholding
The shareholding of Averco Global Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Averco Global Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jun 2025 | 101115129 | State Bank of India | ₹2 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Averco Global Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Averco Global Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Averco Global Private Limited has 1 active EPFO establishment as of Mar 31, 2024.
GST
Averco Global has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAXCA3085B1ZG | Uttar Pradesh | Active | 03 Aug 2022 |
To see the full GST registrations and return filing status of Averco Global Private Limited, buy the company report.
Recent activity
Averco Global Private Limited has 6 board changes on record since 2022: 5 appointments and 1 cessation. The latest: Sri Kant Singh was appointed as CEO on 21 Apr 2025.
Frequently asked questions
Averco Global is an active private limited company based in Noida, Uttar Pradesh, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 08 July 2022 (4+ years old) and is registered under CIN U33119UP2022PTC167319.
Averco Global has 4 current directors and KMP:
- Raman Deep Kaur - Director
- Neeraj Gupta - Director
- Ravi Kant Singh - Director
- Sri Kant Singh - Ceo
The latest financial statements of Averco Global on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Averco Global is 09AAXCA3085B1ZG, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Averco Global is U33119UP2022PTC167319. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Averco Global was incorporated on 08 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Averco Global by revenue are Medizysis India Private Limited, Think Big Systems Private Limited, Celery Pharma Private Limited, all in the Healthcare industry (Medical Consumables), with the same principal business activity (wholesale trading).
Sri Kant Singh was appointed as CEO on 21 Apr 2025. Neeraj Gupta was appointed as Director on 07 Apr 2025. Vijay Kumar Singh ceased to be Whole-Time Director on 13 Jun 2024. Averco Global has 6 board changes on record in total.
Yes, Averco Global is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Averco Global is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0056548).
Averco Global can be reached through the website avercoglobal.com. Its registered office is in Noida, Uttar Pradesh, India.